Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3097978

O=C(O)C(F)(F)F.O=C(O)c1ccc2c(C3CCCCC3)c3n(c2c1)C[C@H](OCCN1CCCC1)COc1ccccc1-3

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 1/20 0.60
MMP12 P39900 1/20 0.60
CACNA1B Q00975 3/20 0.35
SCN9A Q15858 1/20 0.34
NR1I2 O75469 4/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
ESR1 P03372 4/20 0.32
ESR2 Q92731 4/20 0.32
LIPG Q9Y5X9 1/20 0.32
KDM4E B2RXH2 3/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ALDH1A1 P00352 2/20 0.31
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3098231 0.92 PRKCA (0.50) PRKCAMMP12SCN9ANR1I2ESR1
Trifluoroacetic Acid SCHEMBL3093777 0.89 PRKCA (0.72) PRKCAMMP12CACNA1BNR1I2
Trifluoroacetic Acid SCHEMBL3092631 0.89 PRKCA (0.72) PRKCAMMP12CACNA1BNR1I2
Trifluoroacetic Acid SCHEMBL3085041 0.86 PRKCA (0.77) PRKCAMMP12CACNA1BSCN9ANR1I2
SCHEMBL14110783 0.84 PRKCA (0.65) PRKCAMMP12SCN9ANR1I2
SCHEMBL3567161 0.83 PRKCA (0.49) PRKCAMMP12SCN9ANR1I2ESR1
Trifluoroacetic Acid SCHEMBL3080848 0.81 PRKCA (0.63) PRKCAMMP12SCN9ANR1I2
SCHEMBL14110744 0.81 PRKCA (0.67) PRKCAMMP12NR1I2SMN1; SMN2
Trifluoroacetic Acid SCHEMBL3084082 0.80 PRKCA (0.73) PRKCAMMP12SCN9ANR1I2
SCHEMBL4209891 0.80 PRKCA (0.61) PRKCAMMP12SCN9ANR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795247-B2 Tetracyclic indole derivatives as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2010-09-14 US disclosed
US-20060100262-A1 Tetracyclic indole derivatives as antiviral agents ISTITUTO DI RICHERCHEDI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IRMB) (IT) 2006-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100262-A1 Tetracyclic indole derivatives as antiviral agents IDO1, ZC3HAV1, IDO2 PRKCA 3874/4885MMP12 3319/4885CACNA1B 3101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.